相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Outstanding questions in transplantation: Tolerance
Joseph R. Leventhal et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
CAR T-cell product performance in haematological malignancies before and after marketing authorisation
Magdi Elsallab et al.
LANCET ONCOLOGY (2020)
Toward an Optimized Process for Clinical Manufacturing of CAR-Treg Cell Therapy
Enrico Fritsche et al.
TRENDS IN BIOTECHNOLOGY (2020)
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
Birgit Sawitzki et al.
LANCET (2020)
Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports
Douglas E. Gladstone et al.
ANNALS OF INTERNAL MEDICINE (2020)
Regulatory T cells in solid organ transplantation
Muhammad Atif et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
T-reg cell-based therapies: challenges and perspectives
Caroline Raffin et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The Human Genome Editing Race: Loosening Regulatory Standards for Commercial Advantage?
Toni Cathomen et al.
TRENDS IN BIOTECHNOLOGY (2019)
Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans
Petra Bacher et al.
CELL (2019)
Immunoglobulin A Nephropathy. Recurrence After Renal Transplantation
Gabriella Moroni et al.
FRONTIERS IN IMMUNOLOGY (2019)
High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
Dimitrios L. Wagner et al.
NATURE MEDICINE (2019)
Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity
Marco Romano et al.
FRONTIERS IN IMMUNOLOGY (2019)
A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants
James M. Mathew et al.
SCIENTIFIC REPORTS (2018)
Cell Therapy in Organ Transplantation: Our experience on the Clinical Translation of Regulatory T Cells
Niloufar Safinia et al.
FRONTIERS IN IMMUNOLOGY (2018)
A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials
Henrieta Fraser et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Treg cells-the next frontier of cell therapy Will regulatory T cells be a frontline therapy for autoimmunity and other diseases?
Jeffrey A. Bluestone et al.
SCIENCE (2018)
Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance
Qunfang Zhang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation
Marieke van der Zwan et al.
CLINICAL PHARMACOKINETICS (2018)
Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants
S. Chandran et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Regulatory T Cell Specificity Directs Tolerance versus Allergy against Aeroantigens in Humans
Petra Bacher et al.
CELL (2016)
Overcoming Challenges Facing Advanced Therapies in the EU Market
Mohamed Abou-El-Enein et al.
CELL STEM CELL (2016)
Age and gender leucocytes variances and references values generated using the standardized ONE-Study protocol
Anders H. Kverneland et al.
CYTOMETRY PART A (2016)
Recurrent IgA Nephropathy After Kidney Transplantation
Melanie L. Wyld et al.
TRANSPLANTATION (2016)
Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation
Niloufar Safinia et al.
ONCOTARGET (2016)
Human CD45RA- FoxP3hi Memory-Type Regulatory T Cells Show Distinct TCR Repertoires With Conventional T Cells and Play an Important Role in Controlling Early Immune Activation
H. Lei et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Jeffrey A. Bluestone et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Novel GMP-Compatible Protocol Employing an Allogeneic B Cell Bank for Clonal Expansion of Allospecific Natural Regulatory T Cells
S. Landwehr-Kenzel et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Cross-Validation of IFN- Elispot Assay for Measuring Alloreactive Memory/Effector T Cell Responses in Renal Transplant Recipients
O. Bestard et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
TCR Repertoire Analysis by Next Generation Sequencing Allows Complex Differential Diagnosis of T Cell-Related Pathology
M. Dziubianau et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs
Mohamed Abou-El-Enein et al.
CYTOTHERAPY (2013)
Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study
Mathias Streitz et al.
TRANSPLANTATION RESEARCH (2013)
Permanent CNI Treatment for Prevention of Renal Allograft Rejection in Sensitized Hosts Can Be Replaced by Regulatory T Cells
A. Siepert et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
nparLD: An R Software Package for the Nonparametric Analysis of Longitudinal Data in Factorial Experiments
Kimihiro Noguchi et al.
JOURNAL OF STATISTICAL SOFTWARE (2012)
Regulatory immune cells in transplantation
Kathryn J. Wood et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Kidney Transplantation With Minimized Maintenance: Alemtuzumab Induction With Tacrolimus Monotherapy-An Open Label, Randomized Trial
Kakit Chan et al.
TRANSPLANTATION (2011)
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans
Pervinder Sagoo et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Malignancy after renal transplantation: the role of immunosuppression
Ines Rama et al.
NATURE REVIEWS NEPHROLOGY (2010)
Calcineurin Inhibitors in Renal Transplantation Still Needed but in Reduced Doses: A Review
C. Ponticelli et al.
TRANSPLANTATION PROCEEDINGS (2010)
Two Hundred Living Donor Kidney Transplantations Under Alemtuzumab Induction and Tacrolimus Monotherapy: 3-Year Follow-Up
H. P. Tan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Calcineurin Inhibitor Nephrotoxicity
Maarten Naesens et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation
J. A. Bluestone et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Regulatory T cells and immune tolerance
Shimon Sakaguchi et al.
CELL (2008)
Minimization of calcineurin inhibitors to improve long-term outcomes in kidney transplantation
Dela Golshayan et al.
TRANSPLANT IMMUNOLOGY (2008)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Complete avoidance of calcineurin inhibitors in renal transplantation: A randomized trial comparing sirolimus and tacrolimus
TS Larson et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: A systematic review of randomized trials
R Oberbauer
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression:: A multicenter standardized study
WD Döcke et al.
CLINICAL CHEMISTRY (2005)
Immunosuppressive drugs for kidney transplantation
PF Halloran
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Transplantation 50 years later - Progress, challenges, and promises
MH Sayegh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Medical progress - Strategies to improve long-term outcomes after renal transplantation
M Pascual et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
分享论文
